|
|
Article: Emerging Opportunities in Controlled-Release Generic Drugs: New Report Identifies 30 Controlled-Release Drugs Valued at US$15 Billion.
- Article from:
- M2 Presswire
- Article date:
- September 1, 2009
CopyrightCOPYRIGHT 2009 Normans Media Ltd. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
M2 PRESSWIRE-1 September 2009-Research and Markets: Emerging Opportunities in Controlled-Release Generic Drugs: New Report Identifies 30 Controlled-Release Drugs Valued at US$15 Billion(C)1994-2009 M2 COMMUNICATIONS
RDATE:01092009
Dublin - Research and Markets (http://www.researchandmarkets.com/research/a76737/emerging_opportuni) has announced the addition of the "Emerging Opportunities in Controlled-Release Generic Drugs" report to their offering.
This new report identifies 30 controlled-release drugs valued at US$15 billion, many of which will be losing patent protection in the medium term.
From emerging specialist companies to ...